Ticker Details
Bicara Therapeutics Inc. Common Stock
IPO Date:	September 13, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.58B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.65 | 4.09%
Avg Daily Range (30 D):	$0.73 | 2.76%
Avg Daily Range (90 D):	$0.68 | 2.83%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	.46M
Avg Daily Volume (90 D):	.5M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	55

Institutional Trades
Total Institutional Trades:	619
Avg Institutional Trade:	$1.68M
Avg Institutional Trade (30 D):	$1.78M
Avg Institutional Trade (90 D):	$2.08M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.98M
Avg Closing Trade (30 D):	$2.05M
Avg Closing Trade (90 D):	$2.95M
Avg Closing Volume:	106.2K

News

Jun 13, 2026 @ 5:01 AM What Does the Bicara Therapeutics CEO's Sale of 15... Source: Robert Izquierdo

Feb 26, 2026 @ 9:01 PM Bicara Therapeutics Announces Closing of Oversubsc... Source: Globe Newswire

Feb 25, 2026 @ 4:13 AM Bicara Therapeutics Announces Pricing of $150 Mill... Source: Na

Feb 24, 2026 @ 9:01 PM Bicara Therapeutics Announces Proposed Public Offe... Source: Globe Newswire

Dec 15, 2025 @ 1:00 PM Bicara Therapeutics to Present at the J.P. Morgan ... Source: Claire Mazumdar

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.08	$-.82	$-.93
Diluted EPS	$-3.08	$-.82	$-.93
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-185.36M	$-55.44M	$-56.21M
Operating Income / Loss	$-201.99M	$-59.95M	$-60.24M
Cost of Revenue
Net Cash Flow	$-393.11M	$-226.86M	$226.78M
PE Ratio